HCSG
Healthcare Services Group, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$21.82
+0.51%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9B | 1.8B | 1.7B | 1.7B | 1.7B |
| Cost of Revenue | 1.5B | 1.6B | 1.5B | 1.5B | 1.5B |
| Gross Profit | 323.2M | 239.4M | 228.1M | 214.7M | 193.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 192.0M | 190.9M | 174.8M | 160.1M | 149.5M |
| General & Admin Expense | — | — | — | — | 149.5M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 192.0M | 190.9M | 174.8M | 160.1M | 149.5M |
| Cost and Expenses | 1.7B | 1.8B | 1.7B | 1.6B | 1.6B |
| Operating Income (EBIT) | 131.1M | 48.5M | 53.3M | 54.7M | 43.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 1.6M | 1.6M | 6.4M | 7.9M | 3.0M |
| Net Interest Income | (1.6M) | (1.6M) | (6.4M) | (7.9M) | (3.0M) |
| Other Non-Op Income/Expense | 20.3M | 19.3M | (330.0K) | (1.6M) | 764.0K |
| Non-Operating Income (excl Interest) | (11.5M) | (20.9M) | (6.1M) | (6.3M) | (3.8M) |
| EBT (Pre-Tax Income) | 151.4M | 67.9M | 52.9M | 53.1M | 44.6M |
| Income Tax Expense | 28.5M | 8.8M | 13.5M | 14.7M | 10.3M |
| Bottom Line | |||||
| Net Income | 123.0M | 59.1M | 39.5M | 38.4M | 34.2M |
| Earnings from Cont. Ops | 123.0M | 59.1M | 39.5M | 38.4M | 34.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 123.0M | 59.1M | 39.5M | 38.4M | 34.2M |
| Per Share | |||||
| Basic EPS | $1.73 | $0.82 | $0.54 | $0.52 | $0.46 |
| Diluted EPS | $1.71 | $0.81 | $0.53 | $0.52 | $0.46 |
| Revenue Per Share | $26.90 | $25.38 | $23.26 | $22.50 | $22.74 |
| Shares | |||||
| Basic Shares Outstanding | 69.3M | 72.4M | 73.8M | 74.3M | 74.3M |
| Diluted Shares Outstanding | 70.5M | 73.0M | 74.0M | 74.3M | 74.4M |
| Profitability Metrics | |||||
| EBITDA | 150.6M | 86.2M | 74.0M | 75.3M | 62.9M |
| D&A | 7.9M | 16.8M | 14.6M | 14.3M | 15.3M |
| EBIT | 142.7M | 69.4M | 59.4M | 60.9M | 47.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026